Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 355 | 562 | 381 | 14 | 320 |
| Gross Profit | 355 | 562 | 381 | 14 | 320 |
| Operating Expenses | 4,452 | 4,409 | 3,530 | 3,689 | 3,842 |
| Operating Income | -4,097 | -3,847 | -3,150 | -3,675 | -3,523 |
| Other Income | 313 | 377 | 340 | 232 | 318 |
| Pre-tax Income | -3,784 | -3,470 | -2,810 | -3,443 | -3,205 |
| Net Income Continuous | -3,784 | -3,470 | -2,810 | -3,443 | -3,205 |
| Net Income | $-3,784 | $-3,470 | $-2,810 | $-3,443 | $-3,205 |
| EPS Basic Total Ops | -0.64 | -0.58 | -0.67 | -0.88 | -0.86 |
| EPS Basic Continuous Ops | -0.64 | -0.58 | -0.67 | -0.87 | -0.86 |
| EPS Diluted Total Ops | -0.64 | -0.58 | -0.67 | -0.88 | -0.86 |
| EPS Diluted Continuous Ops | -0.64 | -0.58 | -0.67 | -0.87 | -0.86 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.58 | -0.67 | -0.92 | -0.86 |
| EBITDA(a) | $-4,092 | $-3,842 | $-3,144 | $-3,670 | $-3,521 |